AGC Biologics Expands US Fill-Finish via Pyramid Pharma Partnership
- AGC Biologics partners with Pyramid Pharma Services to offer integrated US-based fill-finish services, combining AGC's drug-substance manufacturing with Pyramid's capabilities at its Costa Mesa, California GMP facility.
- Partnership enables clinical-to-commercial supply chain for pre-filled syringes, cartridges, and liquid/lyophilized vials, with flexible project management models and immediate project launches.
Operational Impact
AGC Biologics' Seattle site now offers end-to-end US manufacturing via Pyramid's Orange County fill-finish facility, reducing supply-chain complexity for developers requiring domestic-only production.
Source: BioProcess International RSS
Cytiva Doubles Logan, UT Liquid Media Capacity with New ADCF Facility
- Cytiva completed expansion of its Logan, Utah animal-derived component-free (ADCF) liquid media facility, doubling production capacity with batch sizes now ranging from 700 L to 13,000 L.
- New A1X facility adds three fill lines, six mixing tanks, and upgraded AL6XN stainless-steel equipment designed to shorten cycle time, improve safety, and establish closed-system cleaning.
- Expansion supports supply-chain continuity for cell-culture customers and includes utility infrastructure with 45,000 L and 55,000 L tanks for process water and water-for-injection systems.
Operational Impact
Cytiva's doubled Logan liquid-media capacity and upgraded AL6XN stainless-steel contact surfaces reduce supply risk for CDMO customers dependent on animal-component-free media for large-batch cell-culture manufacturing.
Source: GEN RSS